MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...
In a phase 2 trial, an antiretroviral combination developed by Gilead Sciences and MSD suppressed HIV with a single weekly oral dose, raising the hope of a new treatment option for patients. The new ...
Familiar in form but next-level everywhere else, the Mojo 2 is the The Godfather Part II of DAC sequels Best DACs 2025: USB, desktop and portable digital-to-analogue converters Best portable MP3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback